[{"NetIncomeLoss_2_Q2_USD":-24301000.0,"WeightedAverageNumberOfSharesIssuedBasic_1_Q2_shares":29280000.0,"WeightedAverageNumberOfSharesIssuedBasic_2_Q2_shares":29261000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q2_shares":21000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":573000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":5478000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":4700000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-2103000.0,"InventoryFinishedGoods_0_Q2_USD":36325000.0,"ProceedsFromCollectionOfNotesReceivable_2_Q2_USD":0.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q2_USD":800000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":34000.0,"StockRepurchaseProgramAuthorizedAmount1_0_Q2_USD":3800000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":20062000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":25328000.0,"ProvisionForLoanLossesExpensed_2_Q2_USD":102000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":215000.0,"AssetsCurrent_0_Q2_USD":154187000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":0.0,"ShareBasedCompensation_2_Q2_USD":1787000.0,"Assets_0_Q2_USD":499160000.0,"CommonStockSharesIssued_0_Q2_shares":29323000.0,"UnrecognizedTaxBenefits_0_Q2_USD":900000.0,"OtherNoncashExpense_2_Q2_USD":21000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":110267000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":229564000.0,"FinancingReceivableAllowanceForCreditLosses_0_Q2_USD":277000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":0.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":16106000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":34009000.0,"FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_2_Q2_USD":-11800000.0,"LongTermDebtCurrent_0_Q2_USD":11189000.0,"RestructuringSettlementAndImpairmentProvisions_2_Q2_USD":6005000.0,"LongTermDebt_0_Q2_USD":93189000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":0.0,"ContractWithCustomerLiability_0_Q2_USD":300000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":21070000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":-9661000.0,"Liabilities_0_Q2_USD":290222000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-7009000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-2700000.0,"AccountsReceivableNetCurrent_0_Q2_USD":66545000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-11787000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-11808000.0,"RestructuringCosts_1_Q2_USD":1662000.0,"RestructuringCosts_2_Q2_USD":10066000.0,"RestructuringCosts_6_Q2_USD":27351000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":29261000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":29280000.0,"EarningsPerShareBasic_1_Q2_USD":-0.45,"EarningsPerShareBasic_2_Q2_USD":-0.83,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-1539000.0,"InventoryRawMaterials_0_Q2_USD":26983000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":2572000.0,"CommonStockValue_0_Q2_USD":29000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":24400000.0,"CostOfGoodsAndServicesSoldDepreciationAndAmortization_2_Q2_USD":9039000.0,"CostOfGoodsAndServicesSoldDepreciationAndAmortization_1_Q2_USD":4291000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":2491000.0,"OtherAssetsNoncurrent_0_Q2_USD":1332000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":10539000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-12900000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-23596000.0,"IncreaseDecreaseInInventories_2_Q2_USD":4891000.0,"AssetsHeldForSaleLongLivedFairValueDisclosure_0_Q2_USD":0.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":4627000.0,"RestrictedCash_0_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-21996000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-1345000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.22,"ContractWithCustomerAssetNet_0_Q2_USD":8900000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":9826000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0_Q2_USD":45100000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":24000000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":5080000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":4100000.0,"LegalFees_1_Q2_USD":1763000.0,"InterestExpense_2_Q2_USD":6148000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":1237000.0,"AccountsPayableCurrent_0_Q2_USD":60892000.0,"LiabilitiesCurrent_0_Q2_USD":173914000.0,"InventoryWorkInProcess_0_Q2_USD":7894000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":29280000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":29261000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":18456000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":895000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":297000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":12885000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-16001000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-31310000.0,"Goodwill_0_Q2_USD":69386000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":401000.0,"InterestExpense_1_Q2_USD":3039000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":2491000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":13949000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":-7070000.0,"NetIncomeLoss_1_Q2_USD":-13301000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":170973000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1_Q2_USD":121000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_2_Q2_USD":228000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1526000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":6745000.0,"LinesOfCreditCurrent_0_Q2_USD":77000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":705000.0,"NumberOfOperatingSegments_2_Q2_segment":3.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":2491000.0,"AdditionalPaidInCapital_0_Q2_USD":164068000.0,"FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery_2_Q2_USD":263000.0,"GrossProfit_1_Q2_USD":20637000.0,"GrossProfit_2_Q2_USD":36983000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":12715000.0,"LongTermDebtNoncurrent_0_Q2_USD":82000000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":11784000.0,"LegalFees_2_Q2_USD":1763000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":0.0,"EarningsPerShareDiluted_2_Q2_USD":-0.83,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":7689000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":499160000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":644000.0,"InvestmentIncomeInterest_1_Q2_USD":10000.0,"InvestmentIncomeInterest_2_Q2_USD":18000.0,"InventoryNet_0_Q2_USD":71202000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q2_USD":401000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2_Q2_USD":705000.0,"OperatingIncomeLoss_1_Q2_USD":-1466000.0,"OperatingIncomeLoss_2_Q2_USD":-13935000.0,"CommonStockSharesAuthorized_0_Q2_shares":50000000000.0,"DeferredFinanceCostsNet_0_Q2_USD":811000.0,"TreasuryStockSharesAcquired_2_Q2_shares":0.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1787000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":895000.0,"DeferredFinanceCostsNoncurrentNet_0_Q2_USD":0.0,"OperatingExpenses_2_Q2_USD":50918000.0,"CommonStockSharesOutstanding_0_Q2_shares":29323000.0,"DeferredFinanceCostsCurrentNet_0_Q2_USD":800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":1938000.0,"CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_2_Q2_USD":-1700000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":46944000.0,"InvestmentIncomeDividend_1_Q2_USD":281000.0,"InvestmentIncomeDividend_2_Q2_USD":563000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.45,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":266547000.0,"RestructuringAndRelatedCostExpectedCost1_0_Q2_USD":29000000.0,"LossContingencyEstimateOfPossibleLoss_0_Q2_USD":1800000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":94000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":7407000.0,"StockholdersEquity_0_Q2_USD":208938000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":5357000.0,"OperatingExpenses_1_Q2_USD":22103000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":130904000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":292000.0,"Ticker":"LNDC","CIK":"1005286","name":"LANDEC CORP CA","OfficialName":"Landec Corporation Common Stock (DE)","form":"10-Q","period":"20201130","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"306028744.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210107"}]